Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms
Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms
批准号:
9914375
负责人:
Elysia Poggi Davis
金额:
$69.09万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-07 至 2022-03-31
关键词:
AffectAgeAmericanAmygdaloid structureAnxietyAnxiety DisordersAreaAttentionBehaviorBirthBrainBrain regionChildChild DevelopmentChild Mental HealthChildhoodClinicalCognitiveCommunitiesDataDepressed moodDevelopmentDiseaseEmotionalExposure toFetusFiberFunctional Magnetic Resonance ImagingHippocampus (Brain)HydrocortisoneImpairmentInfantInfant DevelopmentInterventionKnowledgeLeadLifeLinkLongevityMagnetic Resonance ImagingMeasuresMedical centerMental DepressionMental HealthMeta-AnalysisMood DisordersNational Institute of Mental HealthNegative ValenceNeurologicObservational StudyOccupationalOutcomePhysiologyPostpartum PeriodPrefrontal CortexPregnancyPregnant WomenProcessPsychopathologyPublic HealthRandomizedRandomized Clinical TrialsRecording of previous eventsRecoveryRegulationReportingResearchResearch Domain CriteriaResearch PriorityRestRiskRisk FactorsStructureSystemTestingThickThinnessWomanantepartum depressionbasebehavior observationbrain circuitrycognitive controlcognitive systemconnectomedepressive symptomsdesignethnic diversityexperiencefetalimprovedinfancyinfant outcomeinnovationinterpersonal therapylifetime riskmaternal depressionoffspringprenatalprenatal exposurerecruitsocialsocioeconomicstherapy developmenttranslational impacttreatment as usualvisual trackingwhite matter
中文摘要
项目总结/摘要
暴露于母亲抑郁症状是最确定的风险因素之一,
儿童后期心理病理学的发展。从自然观察研究中积累证据
文件表明,胎儿暴露于母亲抑郁症状与日后儿童精神疾病的风险有关,
健康问题母亲抑郁症是最常见的产前并发症之一,
40%的女性经历抑郁症状水平升高。过去的大多数研究
相关性,因此潜在的因果关系结论有限。这个项目将通过测试
操纵母亲抑郁症状将有利于婴儿结局的假设。在这个项目中,
产妇抑郁症状将减少使用简短的人际关系治疗(IPT),一个完善的,
有效的治疗,并测试这种减少是否会导致婴儿发育的改善
与以后精神病理学风险相关的机制。符合NIMH的研究优先级
领域标准(RDoC)为基础的过程,我们将评估婴儿的多个措施,评估
来自负价系统的潜在威胁(“焦虑”)和来自负价系统的认知(努力)控制
认知系统。我们建议评估300名报告抑郁水平升高的孕妇,
症状和婴儿。在干预之前,将收集产妇测量数据。然后一半的
妇女将随机接受IPT,另一半将接受加强的常规护理。完成后
在干预措施中,将纵向收集产后14个月的产妇测量结果。婴儿
将在出生时以及7个月和14个月矫正年龄时进行评估。婴儿将在四个单位进行评估,
分析(大脑结构和功能,生理学,行为和母亲报告)。
英文摘要
Project Summary/Abstract
Exposure to maternal depressive symptoms is one of the most well established risk factors for the
development of later child psychopathology. Accumulating evidence from naturalistic observational studies
documents that fetal exposure to maternal depressive symptoms is associated with risk for later child mental
health problems. Maternal depression is one of the most common prenatal complications with approximately
40% of women experiencing elevated levels of depressive symptoms. The majority of past research has been
correlational, so potential causal conclusions have been limited. This project will break new ground by testing
the hypothesis that manipulating maternal depressive symptoms will benefit infant outcomes. In this project,
maternal depressive symptoms will be reduced using brief interpersonal therapy (IPT), a well-established and
efficacious treatment, and testing whether this reduction leads to an improvement in the development of infant
mechanisms associated with risk for later psychopathology. Consistent with NIMH's priority of Research
Domain Criteria (RDoC)-based processes, we will assess infants with multiple measures that assess the
constructs of potential threat (“anxiety”) from the Negative Valence System and cognitive (effortful) control from
the Cognitive System. We propose to assess 300 pregnant women who report elevated levels of depressive
symptoms and their infants. Prior to the intervention, maternal measures will be collected. Then half of the
women will be randomized to receive IPT and the other half will receive enhanced usual care. After completion
of the intervention, maternal measures will be collected longitudinally through 14 months postpartum. Infants
will be evaluated at birth and at 7- and 14-months corrected age. Infants will be assessed across four units of
analysis (brain structure and function, physiology, behavior, and maternal-report).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Group-based Prevention of Postpartum Depression: In-person vs. Virtual Delivery
-
批准号:10523797
-
项目类别:
-
资助金额:$75.79万
-
财政年份:2022
-
负责人:Elysia Poggi Davis
-
依托单位:
Group-based Prevention of Postpartum Depression: In-person vs. Virtual Delivery
-
批准号:10674881
-
项目类别:
-
资助金额:$74.52万
-
财政年份:2022
-
负责人:Elysia Poggi Davis
-
依托单位:
Reducing maternal prenatal depression to improve child cardiovascular health
-
批准号:10754441
-
项目类别:
-
资助金额:$5.89万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Reducing maternal prenatal depression to improve child cardiovascular health
-
批准号:10326353
-
项目类别:
-
资助金额:$58.26万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Inflammatory trajectories across pregnancy: Investigating novel markers of risk for postpartum depression
-
批准号:10408046
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Inflammatory trajectories across pregnancy: Investigating novel markers of risk for postpartum depression
-
批准号:10217881
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Reducing maternal prenatal depression to improve child cardiovascular health
-
批准号:10851438
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Reducing maternal prenatal depression to improve child cardiovascular health
-
批准号:10543229
-
项目类别:
-
资助金额:$5.89万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Reducing maternal prenatal depression to improve child cardiovascular health
-
批准号:10548740
-
项目类别:
-
资助金额:$67.58万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Reducing maternal prenatal depression to improve child cardiovascular health
-
批准号:10406803
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2021
-
负责人:Elysia Poggi Davis
-
依托单位:
Pre- & Post-natal Exposure to Fragmented Maternal Signs: Infancy to Adolescence
-
批准号:9355815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Elysia Poggi Davis
-
依托单位:
Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities
-
批准号:10186817
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2013
-
负责人:Elysia Poggi Davis
-
依托单位:
Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities
-
批准号:10595598
-
项目类别:
-
资助金额:$44.16万
-
财政年份:2013
-
负责人:Elysia Poggi Davis
-
依托单位:
Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities
-
批准号:10379270
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2013
-
负责人:Elysia Poggi Davis
-
依托单位:
Vulnerability to Prenatal Glucocorticoids Programs Infant Development
-
批准号:8122249
-
项目类别:
-
资助金额:$52.59万
-
财政年份:2010
-
负责人:Elysia Poggi Davis
-
依托单位:
Vulnerability to Prenatal Glucocorticoids Programs Infant Development
-
批准号:7949930
-
项目类别:
-
资助金额:$50.38万
-
财政年份:2010
-
负责人:Elysia Poggi Davis
-
依托单位:
Vulnerability to Prenatal Glucocorticoids Programs Infant Development
-
批准号:8288726
-
项目类别:
-
资助金额:$51.54万
-
财政年份:2010
-
负责人:Elysia Poggi Davis
-
依托单位:
Vulnerability to Prenatal Glucocorticoids Programs Infant Development
-
批准号:8676836
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2010
-
负责人:Elysia Poggi Davis
-
依托单位:
Vulnerability to Prenatal Glucocorticoids Programs Infant Development
-
批准号:8469873
-
项目类别:
-
资助金额:$47.25万
-
财政年份:2010
-
负责人:Elysia Poggi Davis
-
依托单位:
Quality of Maternal Care Moderates the Developmental Consequences of Exposure to
-
批准号:7816825
-
项目类别:
-
资助金额:$7.65万
-
财政年份:2009
-
负责人:Elysia Poggi Davis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: